Navigation Links
Study Confirms Soy Isoflavones Reduce Menopausal Hot Flashes
Date:4/4/2012

DECATUR, Ill., April 4, 2012 /PRNewswire/ -- Archer Daniels Midland Company (NYSE: ADM) is pleased to share the results of a new meta-analysis on the effects of soy isoflavones in the alleviation of menopausal hot flashes. The analysis, which was published March 19 by Menopause: The Journal of The North American Menopause Society, found clear and consistent evidence that soy isoflavone supplements, like NovaSoy brand soy isoflavones, are significantly more effective than placebo in reducing the frequency and severity of hot flashes.

"The key finding in this study is that when you limit the analysis to isoflavone supplements derived from soy or those with profiles identical to soy, there is a very consistent effect on hot flash relief," said Mindy S. Kurzer, Ph.D, professor of nutrition at the University of Minnesota, hormone expert and contributing author to the study. "Almost all studies in the meta-analysis show a consistent reduction in hot flash frequency and severity."

The meta-analysis – which is the largest and most comprehensive conducted to date – revealed that ingestion of soy isoflavones for six weeks to 12 months significantly reduced the frequency of hot flashes by more than 20 percent compared with placebo. Soy isoflavones also significantly reduced hot flash severity by more than 26 percent compared with placebo. The analysis found that the decrease in hot flash frequency in longer duration trials (more than 12 weeks) was approximately threefold greater than the decrease in shorter-duration trials.

"For women who are bothered by hot flashes, any reduction in frequency or severity may be welcome – especially if it can be achieved without side effects," said Melissa K. Melby, Ph.D (University of Delaware), hot flash expert and contributing author to the study. "Soy isoflavones appear to be a good first approach to
'/>"/>

SOURCE Archer Daniels Midland Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... FRANCISCO , May 18, 2013 ... MadinAmerica.com , Occupy Psychiatry , ... mental health care, announces a social media campaign ... the traditional psychiatric model, which focuses on pathology ... launch coincides with the American Psychiatric Association,s (APA) ...
(Date:5/17/2013)... May 17, 2013 The power of plants ... ways in which mankind depends on the plant kingdom, ... multifaceted exhibition Wild Medicine: Healing Plants ... on view from May 18 through September 8, 2013. ... The featured exhibition,s many attractions include a re-creation of ...
(Date:5/17/2013)... 2013  Lakeland Industries, Inc. (NASDAQ: LAKE ... industry, healthcare and to first responders on the federal, ... for the fiscal 2013 fourth quarter and year ended ... stock market close and will conduct a conference call ... (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) The ...
Breaking Medicine Technology:New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2
... Sanofi Pasteur, the vaccines division of the sanofi-aventis Group ... today that the U.S. Food and Drug Administration (FDA) ... meningococcal conjugate vaccine, Menactra® (Meningococcal [Groups A, C, Y ... a two-dose schedule for infants and children 9 months ...
... N.C., April 22, 2011 The growing importance of ... to manage rapidly changing regulatory requirements in today,s biopharmaceutical ... companies anticipate an increase in medical affairs funding of ... on the minds of medical affairs executives is insufficient ...
Cached Medicine Technology:Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants 2Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants 3Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants 4Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants 5Pharmaceutical Medical Affairs Functions Get a Boost in Budget, Staffing 2
(Date:5/19/2013)... 2013 Healthcare leaders will gather at ... the Walt Disney World Swan and Dolphin in Orlando, ... innovation, care delivery and healthcare reform and implementation. , ... healthcare markets, with consolidation, efficiency and reduced ... Todd Ebert, Amerinet president and CEO. “There is a ...
(Date:5/19/2013)... People in Minnesota have a great option to get ... 28 Day Fat Loss Formula. The best part is ... own home. The product sells for $135 dollars and is ... here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is almost here. ... after using the 28 Day Fat Loss Formula they will ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Actos ... federal litigation now underway in U.S. District Court, Western ... Order dated May 3rd, the Court has modified the ... to eight cases rather than four. The next Status ... Thursday, May 23rd. (In re: Actos Product Liability Litigation, ...
(Date:5/19/2013)... Utah (PRWEB) May 19, 2013 ... on small business health insurance . Zane ... traditional employer sponsored health benefits, is the leader ... and health reimbursement arrangements . , According ... and the self-employed intrinsically know the value of ...
(Date:5/19/2013)... According to a new market research report "Image ... By Applications (Healthcare (Endoscopy, Radiology, Ophthalmology), Surveillance, Automobile, ... Infrared, X-Ray) And Geography" published by MarketsandMarkets, the ... in 2012 and is expected to reach $10.75 ... 3.84% from 2013 to 2018. In terms of ...
Breaking Medicine News(10 mins):Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3
... Washington, in Seattle, a group of engineers has recently emerged ... surgical robot// to deploy in far-flung places, with a doctor ... groups all over the world have long been interested in ... who lives and who dies. A recent study of combat ...
... Duke University biomedical engineers have announced that they ... the effectiveness of the topical microbicides// used by ... microbicides are needed since the infections globally are ... and chemistry, the researchers developed a computer model ...
... have discovered that a protein called ABCB6 plays a central ... the ability// of red blood cells to carry oxygen, of ... extract energy from nutrients. ,The St. Jude investigators ... the cell’s energy powerhouse called the mitochondria; and that it ...
... performing on par with other children from single births ... twins// has been found wanting and they fared less ... because twins receive less attention from parents as well ... study of 11,000 youngsters shows that twins are catching ...
... and older Americans have been declining since the early 1990s. ... ,Those are the findings of a study conducted ... Thursday (Sept. 28) in the October issue of the American ... professor and associate dean for research at the University of ...
... at the Broad Institute of MIT and Harvard announced today ... can connect human diseases// with potential drugs to treat them, ... cells. Called the 'Connectivity Map,' the new tool and its ... and in separate publications in the September 28 immediate early ...
Cached Medicine News:Health News:Doc at a Distance 2Health News:Computer Tool Predicts Effectiveness Of Microbicides 2Health News:Computer Tool Predicts Effectiveness Of Microbicides 3Health News:ABCB6 Is Key to Production of Heme in Hemoglobin 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 3Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 2Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 3
4Fr, 5Fr & 6Fr diagnostic electrophysiology catheters with fixed curves....
... range of fixed curve catheters designed to ... and other patients with small anatomies. Each ... only the finest materials. A unique multi-step ... extrusion technologies results in the excellent torque ...
... To aid clinicians in performing Ankle/Brachial Index ... new, complete packet of information. It includes ... that can be viewed on any computer ... step-by-step procedure of performing an ABI test, ...
... VERICIS PhysioLog Hemodynamic Monitoring and Data ... system for the cath lab, integrating ... Waveform analysis , Data collection , ... Image capture/analysis , Procedural reporting ...
Medicine Products: